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t e c h n i c a l r e p o r t s
The application of primary organoid cultures containing epithelial and mesenchymal elements to cancer modeling holds promise for combining the accurate multilineage differentiation and physiology of in vivo systems with the facile in vitro manipulation of transformed cell lines. Here we used a single air-liquid interface culture method without modification to engineer oncogenic mutations into primary epithelial and mesenchymal organoids from mouse colon, stomach and pancreas. Pancreatic and gastric organoids exhibited dysplasia as a result of expression of Kras carrying the G12D mutation (Kras G12D ), p53 loss or both and readily generated adenocarcinoma after in vivo transplantation. In contrast, primary colon organoids required combinatorial Apc, p53, Kras G12D and Smad4 mutations for progressive transformation to invasive adenocarcinoma-like histology in vitro and tumorigenicity in vivo, recapitulating multi-hit models of colorectal cancer (CRC), as compared to the more promiscuous transformation of small intestinal organoids. Colon organoid culture functionally validated the microRNA miR-483 as a dominant driver oncogene at the IGF2 (insulin-like growth factor-2) 11p15.5 CRC amplicon, inducing dysplasia in vitro and tumorigenicity in vivo. These studies demonstrate the general utility of a highly tractable primary organoid system for cancer modeling and driver oncogene validation in diverse gastrointestinal tissues.
The in vitro culture of primary, nontransformed tissues as threedimensional structures that accurately recapitulate organ structure, multilineage differentiation and physiology has diverse applications ranging from basic biology to therapy 1, 2 . Three-dimensional cultures of glandular organs can be subdivided into those with exclusively epithelial components and those with both epithelial and mesenchymal components. Although the term 'organoid' has been used generically for three-dimensional structures possessing multiple cell lineages and tissue architectures, a recent proposal suggested that this term be restricted to cultures containing both epithelium and mesenchyme 3 .
Recent studies have described methodology for the threedimensional culture of purely epithelial cell preparations from primary gastrointestinal tissues such as pancreas, stomach and intestine, often using specific growth factor supplementation to supply paracrine or mesenchymal signals 2, [4] [5] [6] [7] [8] . In contrast, we robustly cultured organoids with both epithelial and mesenchymal components from small intestine, colon and stomach using an air-liquid interface methodology that does not require exogenous growth factor supplementation 9, 10 . In this system, intestinal organoids exhibit multilineage differentiation and supporting mesenchyme, sustained growth for >350 days, recapitulated intestinal stem cells and their endogenous Wnt-Notch paracrine signaling niche and peristalsis 9 . Similarly, airliquid interface gastric organoids accurately recapitulate the differentiation and ultrastructure of stomach cell lineages for >30 days 10 .
Despite having the advantages of accurate organ ultrastructure, stromal composition and ease of experimental manipulation, primary organoid culture of diverse normal tissues has been underutilized for in vitro modeling of cancer. Recently, Ghajar and Bissell advanced the holistic notion of 'cancer engineering' , describing the need for complex in vitro cell culture models of cancer that incorporate heterologous interactions between the epithelium and diverse stromal cell types to interrogate both epithelial and microenvironmental aspects of malignancy 11 . Potential applications of such highly accurate epithelial and mesenchymal models include cancer therapeutic validation and functional validation of putative oncogenic loci from an untransformed baseline tabula rasa. Indeed, the complexity and chaos of tumor genomes revealed by genome-scale sequencing efforts such as The Cancer Genome Atlas Project (TCGA) and others 12 Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture have highlighted the necessity for new in vitro methods to functionally validate putative oncogenic loci and distinguish them from passenger mutations.
In the present study, we address these needs through the demonstration that a single air-liquid interface method can robustly model diverse gastrointestinal malignancies from pancreas, stomach and colon in primary epithelial and mesenchymal organoid culture, yielding detailed in situ histologic endpoints for oncogenic transformation in vitro and tumorigenicity after transplantation in vivo. Further, we systematically assessed the requirements for combinatorial oncogenic transformation in colon organoids, obtaining in vitro reprogramming of primary intestinal epithelium to adenocarcinoma and recapitulating multi-step colon tumorigenesis. We also demonstrate proof of principle for the application of primary organoid culture to driver oncogene validation through interrogation of the 11p15.5 colon cancer amplicon containing IGF2 and miR-483.
RESULTS

Growth and transformation of primary pancreatic organoids
Various methods have been employed successfully for the primary culture of pancreatic ductal cells without stromal components, including monolayer and three-dimensional culture of ductal populations as compared to single cells [5] [6] [7] [8] 13, 14 . However, long-term pancreatic organoid culture containing epithelial and mesenchymal elements has not been described. Here we cultured mouse pancreatic explants using our colon and gastric air-liquid interface culture method using an inner collagen gel-containing transwell with direct air exposure 9, 10 . Accordingly, we cultured neonatal pancreatic organoids from wildtype C57BL/6 mice in an air-liquid interface, where they exhibited progressive expansion for >30 days as cystic structures containing an epithelial layer and surrounding fibroblasts, similar to our prior studies with intestine and stomach 9,10 , and were readily infected with adenovirus ( Fig. 1a) . These organoids consisted predominantly (>90%) of E-cadherin-positive (E-cad + ) and Pdx1 + ductal epithelium with a cystic morphology and PCNA + proliferating cells in association with α-smooth muscle actin-positive (SMA + ) stromal cells ( Fig. 1a,b) . We observed expression of somatostatin and insulin in rare islet-like regions that were either independent from or associated with ductal structures (Fig. 1b) ; sporadic immunoreactivity for glucagon and amylase was occasionally present (data not shown).
The predominance of ductal structures within the pancreatic organoids suggested their utility for modeling pancreatic ductal adenocarcinoma. Accordingly, we generated primary pancreatic organoids from mice with floxed alleles of Kras G12D (lox-stop-lox (LSL) npg Kras G12D ), p53 (p53 flox/flox ) or both (LSL Kras G12D ; p53 flox/flox ) by analogy to prior seminal in vivo studies 15 . We infected the organoids at the time of plating with adenovirus expressing Cre-GFP (Ad Cre-GFP) or a control immunoglobulin Fc fragment (Ad Fc) and assessed appropriate epithelial expression of Kras G12D or P53 loss by immunofluorescence ( Supplementary Fig. 1a ). Throughout this manuscript, Cre-treated organoids are denoted as K (expressing Kras G12D ), P (p53 null) or KP (expressing Kras G12D and p53 null). Oncogene-transformed K, P and KP pancreatic organoids could be serially passaged (>6 passages, the longest time evaluated) in contrast to Ad Fc-infected controls (Supplementary Fig. 1b ). By 50 days of culture, K, and KP pancreatic organoids exhibited marked dysplasia with enlarged pleomorphic nuclei with stratification, cribriform growth and marked areas of invasion. P organoids did not exhibit invasion but did possess mildly stratified nuclei with moderate nuclear enlargement; these alterations encompassed ~10% of the epithelium for K and P organoids and >30% for KP organoids (Fig. 1c) . The oncogene-transformed pancreatic organoids could be readily infected with retrovirus or lentivirus at the time of passage, in contrast to Ad Fc-infected controls ( Supplementary Fig. 1c and data not shown).
We repassaged FACS-sorted EpCAM + epithelium from these primary pancreatic organoids into a 96-well air-liquid interface culture, allowing for both robust secondary organoid formation and multiplexed quantification of proliferation using the fluorescent dye calcein, AM. The use of light-impermeable FluoroBlok membranes in the transwell allows for simultaneous quantification of vertical invasion through the filter (bottom fluorescence) and proliferation (total fluorescence). In this assay, KP organoids exhibited significantly increased proliferation and invasion (P < 0.05 for KP compared to K or P) ( Supplementary Fig. 2a,b) .
Notably, dissociated K, P and KP organoids all demonstrated in vivo tumorigenicity within 30 days of subcutaneous (s.c.) transplantation into immunodeficient NOG mice, indicating full oncogenic transformation. These transplanted tumors all represented moderately or poorly differentiated invasive adenocarcinoma, containing foci of invasive glands lined by cells with enlarged pleomorphic nuclei and focal cytoplasmic mucin admixed with adjacent less-differentiated regions exhibiting glandular effacement, in agreement with prior in vivo studies 15 ; KP and P organoids were more poorly differentiated than K organoids, and KP tumor size exceeded that of K or P ( Fig. 1d and Supplementary Fig. 2c ). Areas of glandular differentiation expressed E-cadherin and the ductal markers PanCK 8 and CK19 (ref. 15 ), confirming the epithelial origin of these adenocarcinomas ( Fig. 1d) ; in nonglandular regions, E-cadherin expression was lost ( Supplementary Fig. 2d ). These studies demonstrate not only the development of a model for sustained primary pancreatic organoid cultures but also its successful application to pancreatic ductal adenocarcinoma modeling with detailed histologic endpoints in vitro and tumorigenicity in vivo.
Oncogenic transformation of primary gastric organoid cultures
We similarly examined the oncogenic transformation of gastric organoids in air-liquid interface culture. As described recently by one author of this study (A.O.) 10 , primary gastric organoids from wild-type neonatal mice can be robustly propagated as progressively enlarging cystic structures for >30 days. Histologically, the gastric organoids exhibited a well-differentiated epithelial layer comprised of surface mucous cells and, to a lesser extent, mucous neck cells with peripherally located myofibroblasts, which were confirmed by E-cadherin and SMA immunofluorescence ( Fig. 2a) . We also observed npg t e c h n i c a l r e p o r t s regions of H + /K + -ATPase expression and periodic acid Schiff (PAS)positive mucous-producing cells ( Fig. 2a) .
To model gastric cancer, we generated primary organoids from the glandular stomach of K, P or compound KP mice, modeling the p53 loss and KRAS mutations that are present in approximately 50% and 5% of gastric cancers, respectively. Inclusion of Ad Cre-GFP at the time of primary plating resulted in efficient adenoviral infection ( Fig. 2a ) accompanied by epithelial overexpression of Kras G12D in K and KP organoids, as well as loss of epithelial P53 immunoreactivity in P organoids (Supplementary Fig. 3a) .
Similarly to the pancreatic organoids, oncogene-transformed K, P and KP gastric organoids could be serially passaged (>6 passages, the longest time evaluated), in contrast to Ad Fc-infected controls ( Supplementary  Fig. 3b ). After 50 days of culture, K, P and KP gastric organoids all exhibited in vitro histologic dysplasia that was most profound with KP organoids and was characterized by invasive tumor cells containing highly pleomorphic and enlarged nuclei and regional complex cribriform growth patterns associated with necrosis. K and P gastric organoids exhibited relatively milder degrees of in vitro dysplasia, with cellular stratification, nuclear enlargement and pleiomorphism (Fig. 2b) . These alterations represented approximately ~30-40% of the epithelium for K organoids, 10% for P organoids and ~80% for KP organoids despite uniform Kras G12D expression and p53 loss (Supplementary Fig. 3a) . Also similar to pancreatic organoids, K, P and KP gastric organoids were readily infected with lentivirus and retrovirus, in marked contrast to wild-type controls ( Supplementary Fig. 3c and data not shown).
In 96-well air-liquid interface proliferation and invasion assays, KP organoids exhibited significantly increased proliferation and invasion (P < 0.05 for KP compared to K or P) ( Supplementary Fig. 4a ). Subcutaneous transplantation of K, P and KP organoid-dissociated cells all induced in vivo tumorigenicity within 30 days of inoculation into immunodeficient NOG mice ( Fig. 2c and Supplementary Fig. 4b ).
All modules produced high-grade invasive carcinomas composed of malignant cells with enlarged, hyperchromatic nuclei, numerous mitotic figures and variable amounts of eosinophilic cytoplasm. KP tumors were higher grade than K or P tumors and exhibited decreased glandular architecture, more nuclear pleomorphism and an absence of identifiable intracytoplasmic mucin vacuoles. Regions of glandular differentiation for all genotypes were E-cadherin-and CK19 (KRT19)positive ( Fig. 2c and data not shown), but nonglandular regions were negative for E-cadherin ( Supplementary Fig. 4c ). These results indicate the successful modeling of oncogenic loci in primary gastric organoids with robust in situ histologic readouts in vitro and neoplastic transformation in vivo, accurately recapitulating numerous aspects of human gastric cancer progression.
Multi-hit colorectal tumorigenesis in colon organoids
During CRC, polyposis is typically initiated by baseline APC mutations, with subsequent accumulation of additional mutations (for example, KRAS, P53 or SMAD4) being required to develop metastatic adenocarcinoma. Additional signaling pathways undergoing frequent alteration in CRC include epidermal growth factor receptor (EGFR), BRAF and phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) [16] [17] [18] . We applied the ability to propagate long-term epithelial and mesenchymal intestinal organoid cultures 9 to CRC modeling. Accordingly, we treated small intestine or colon organoids from Apc flox/flox ; villin-CreER mice 19, 20 with tamoxifen in vitro, inducing epithelial-specific Apc deletion and marked hyperproliferation without substantial dysplasia or invasion over a 20-day period (Fig. 3a,b) . Over extended time points (>100 days), we observed in situ polyposis within the walls of Apc-null small intestinal organoids, with proliferation of closely spaced tubules lined by mildly enlarged, crowded nuclei that recapitulated human tubular adenomatous polyps (Fig. 3c,d) .
We examined the multi-hit requirement for CRC development in primary colon organoids by systematically comparing one-, two-, three-and four-oncogene modules engineered by combinations of CreER-mediated Apc deletion (A) and ecotropic retroviruses encoding Kras G12D (K), npg p53 shRNA and GFP (P) and/or Smad4 shRNA and GFP (S) (Fig. 3e) .
Adult Apc-null colon organoids (Apc flox/flox ; villin-CreER plus tamoxifen) are extremely permissive to retroviral or adenoviral infection ( Supplementary Fig. 5 ). Both the one-gene Apc-null (A) module and the two-gene modules Apc and Kras G12D (AK), Apc and p53 shRNA (AP) and Apc and Smad4 shRNA (AS) elicited only minimal dysplasia in colon organoids even after 50 days of culture, predominantly exhibiting a well-organized, stereotyped epithelial monolayer organization (Fig. 3e) . However, among three-gene modules with different combinations of Apc, Kras G12D , p53 shRNA or Smad4 shRNA, the AKP module was notable for its high-grade focal dysplasia with nuclear pleiomorphism and necrosis, either as a result of retroviral engineering (Fig. 3e) or after Ad Cre-GFP infection of organoids from Apc flox/flox ; LSL Kras G12D ; p53 flox/flox mice 21 (AKP*) (Fig. 4a) ; we observed lesser dysplasia with the AKS and APS modules. The Apc, Kras G12D , p53 shRNA and Smad4 shRNA four-gene module (AKPS) produced an even more severe transformation, ranging from confluent sheets of cells to cribriform growth patterns with luminal necrosis and jagged infiltration typical of human colorectal adenocarcinoma ( Fig. 3e and Supplementary Fig. 6 ).
Transformed colon AKPS foci represented ~10-20% of the total epithelium as compared to ~5% for the other genotypes and required ~50 days to manifest. We confirmed Kras G12D expression, knockdown of p53 and Smad4 and the epithelial origin of E-cadherin expression (Fig. 4b,c) . A dysplasia index incorporating blinded pathologic examination of proliferation, nuclear atypia, invasion and cellular stratification indicated a direct correlation in colon organoids between oncogene module complexity and degree of transformation ( Fig. 4d) . Thus, colon organoids accurately recapitulate classical multi-hit CRC models requiring multiple mutations for invasive carcinoma 16 .
In contrast to those of the colon, small intestine organoids exhibited more rapid dysplasia (~20-day onset) and stronger transformation sensitivity. We observed high-grade dysplasia even with the small intestine two-gene modules AK and AP, and the four-gene AKPS module exhibited histology that was consistent with invasive adenocarcinoma (Supplementary Figs. 7 and 8) , paralleling the well-established increased susceptibility of mouse small intestine over colon to Apc-mediated tumorigenesis 22 . This relative promiscuity of small intestinal organoids to transformation indicated that colon organoids represent a more optimal in vitro method to model the multi-hit transformation requirements of human CRC.
We further characterized the transformation of colon organoids of the four-gene module (AKPS). After organoid dissociation and replating, Apc-null organoids (A) serially passaged with retention of cystic morphology, but AKPS organoids exhibited massive expansion, frequently as solid tumor masses ( Fig. 4e) . AKPS but not A organoids grew in two dimensions on tissue culture plastic and exhibited focus formation (Fig. 4f) . Further, AKPS but not A cells exhibited robust in vivo tumorigenicity within 50 days of s.c. transplantation (10/10 compared to 0/10 mice, respectively), indicating full oncogenic transformation (Fig. 4g,h) . These transplanted tumors expressed the epithelial markers villin and E-cadherin, were highly proliferative and npg t e c h n i c a l r e p o r t s represented poorly differentiated adenocarcinoma with occasional mucinous features (Fig. 4g) .
miR-483 is a driver oncogene in the 11p15.5 CRC amplicon
To demonstrate the utility of the primary colon organoid system for oncogene discovery applications, we functionally validated a putative CRC locus from the TCGA CRC survey. The 11p15.5 amplicon containing IGF2, its intronic microRNA miR-483, INS and TH occurs in 7% of CRC TCGA cases 12 (Fig. 5a) and is typically co-mutated with APC but not KRAS, P53 or SMAD4 (http://www.cbioportal.org). As only IGF2 and miR-483 are co-overexpressed from this amplicon 12 , we performed contextual modeling overexpressing Igf2, miR-483 or both in Apc-null colon organoids. Notably, overexpression of miR-483 (AM) but not Igf2 (AI) elicited high-grade dysplasia of Apc-null organoids with nuclear pleiomorphism and epithelial stratification ( Fig. 5b and  Supplementary Fig. 9a ). We further confirmed prominent epithelial dysplasia by E-cadherin immunofluorescence, which was present with overexpression of miR-483 but not Igf2 (Supplementary Fig. 9b) . miR-483 strongly increased the dysplasia index of A organoids ( Fig. 5c ; P < 0.001, A compared to AM), in contrast to the lack of AK, AP or AS two-gene module effects on dysplasia index (Fig. 4d) and consistent with the particularly robust Apc and miR-483 transforming synergy in organoid culture. Dysplasia was induced, to a lesser degree, by Igf2 overexpression (Fig. 5c ; P = 0.036, A compared to AI). Further, npg Igf2 and miR-483 oncogene cooperation was suggested by the dysplasia index of the Apc, Igf2 and miR-483 three-gene module (AIM) compared to that of the Apc and miR-483 (AM) module ( Fig. 5c ; P = 0.0487, AM compared to AIM). Notably, miR-483 exhibited potent transforming activity in vivo, as colon AM organoids robustly gave rise to tumors after s.c. transplantation, in contrast to two-gene modules containing Apc and IGF2, Kras G12D , p53 shRNA or Smad4 shRNA (AI, AK, AP and AS, respectively), from which tumors did not arise by 50 days (Fig. 5d) .
In the multiplexed proliferation and invasion assay, miR-483 increased the invasion of Apc-null cells (P < 1 × 10 −7 ), in contrast to the weaker but significant effects from Igf2 (P < 0.03) (Fig. 5e) . In addition, miR-483 (P < 0.00003), but not Igf2, significantly increased the proliferation of Apc-null organoids (Fig. 5e) . In contrast to the dysplasia index, the combination of Igf2 and miR-483 did not additively stimulate proliferation (P = 0.66) or invasion (P = 0.07) ( Fig. 5e ; AM compared to AIM).
To identify potential miR-483-repressed targets that could mediate its transforming effects in colon cancer, we identified 122 genes with a false discovery rate <0.05 that were repressed in miR-483-amplified TCGA human colorectal cancers by searching for an inverse correlation between gene expression and copy number in 191 matched patients from the colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) data sets 12 . We restricted this list further to genes containing computationally predicted miR-483 seed sequences, yielding 11 loci (ABTB1, ACBD4, APBA2, CREBL2, KREMEN2, LTBP4, METRN, PDLIM2 (SLIM), PORCN, RUSC1 and ZCWPW1). Filtering further for seed sequence matches that were conserved between mouse and human yielded two loci (ABTB1 and PDLIM2) that we selected for investigation ( Supplementary Fig. 10a ). Lentiviral overexpression of miR-483 repressed Pdlim2 and Abtb1 in colon organoids (Fig. 5g) . Further, overexpression of PDLIM2 but not ABTB1 reversed miR-483-induced proliferation and invasion in Apc and miR-483 colon organoids (AM), whereas shRNA knockdown of Pdlim2 but not Abtb1 was sufficient to induce proliferation and invasion of Apc-null (A) colon organoids ( Fig. 5f and Supplementary  Fig. 10b,d,e) ; miR-483 expression strongly repressed mouse and human PDLIM2 3′ untranslated region (UTR)-luciferase biosensor constructs (Supplementary Fig. 10c) . These data support a model in which PDLIM2, encoding a E3 ubiquitin ligase that represses STAT function 23 , is a physiologically relevant mediator of miR-483transforming effects in CRC (Fig. 5h) .
DISCUSSION
These studies describe the general application of a single primary organoid culture method without modification to the in vitro modeling of diverse pancreatic, gastric and colon gastrointestinal malignancies. Notably, this air-liquid interface methodology robustly supports organoid growth as epithelial and mesenchymal hybrids without exogenous growth factor supplementation and allows in vitro cancer modeling in a more physiologic milieu than has been achieved previously using transformed cell lines or exclusively epithelial primary cultures. We also extend our previous work 9,10 to the successful long-term culture of wild-type pancreatic epithelial and mesenchymal organoids as opposed to epithelium-only [5] [6] [7] [8] 13, 14 or short-term embryonic pancreatic organoid cultures 24, 25 .
One advantage of this method is the generation of extremely detailed in situ histologic endpoints for dysplasia and transformation in the three-dimensional organoid context. Such profound in vitro histologic changes have not been reported to result from oncogene manipulation in previous epithelial-only organotypic modeling of pancreatic or intestinal cancer 26, 27 or three-dimensional cultures of immortalized breast or lung cell lines 26, 28 . The ability to model and histologically document malignant progression completely in vitro without reliance on in vivo transplantation is a substantial advance for cancer investigation. This highly tractable system greatly facilitates the ability to engineer combinatorial oncogene modules in primary cultures through the use of mouse floxed oncogenic alleles superimposed on efficient transduction with a variety of viral vectors. Combinatorial gene manipulation is highly relevant given the frequency of co-mutated loci in cancer genomes 12 , and the use of ecotropic retroviruses further affords a safety factor for the manipulation of oncogenic loci. For both pancreatic and gastric organoids, we observed pronounced histologic dysplasia with combinatorial Kras and p53 mutations. In colon organoids, we found progressive transformation with increasing complexity of the introduced gene modules, accurately recapitulating multi-hit models of human CRC development 12, 16 and culminating with pronounced histologic transformation using the four-gene AKPS module. In contrast, the promiscuous transformation susceptibility of small intestinal organoids in our studies, even with two-gene modules, strongly suggests that prior attempts at three-dimensional modeling of CRC in small intestine epithelial organoids 27 were both less than optimal compared with our present colon-based approaches and consonant with the well-documented increased susceptibility of the mouse small intestine over colon to Apc-mediated tumorigenesis in vivo 22 . To our knowledge, the AKPS module represents the first in vitro conversion of primary colon tissue to colon adenocarcinoma as judged by multiple criteria, including histologic transformation, focus formation and robust in vivo tumorigenicity after transplantation.
The oncogenic transformation of diverse gastrointestinal organoids to a fully malignant phenotype, as in the current studies, is strongly supported by in vivo tumorigenicity. Transplanted pancreatic and gastric organoids readily generated invasive adenocarcinoma with admixtures of glandular and less differentiated nonglandular areas, consistent with mouse transgenic and induced pluripotent stem cell (iPS)-based approaches 15, 29 . Although colon AM and AKPS modules exhibited poorly differentiated high-grade tumors, it will be interesting to assess whether more-differentiated colon tumors could arise from one-to three-gene colon modules over extended time points and we have recently observed glandular and metastatic colon tumors upon transplantation of other oncogene modules (X.L. and C.J.K., unpublished data). As the organoids were in a hybrid background, the tumor transplantation studies occurred in immunodeficient mice, which are probably a permissive setting for tumorigenesis.
The substantial catalog of genomic aberrations in malignant cells revealed by unbiased genome-scale surveys of cancer 12 has highlighted the need for robust methods for large-scale, systematic functional validation of putative cancer driver loci 30 . Our functional studies with miR-483 provide proof of principle for primary organoid validation of putative drivers, have the potential to combine the histologic accuracy of in vivo studies 31, 32 with the experimental tractability of transformed cell lines 33, 34 and complement both of these techniques. The unexpected identification of miR-483 and not Igf2 as the predominant driver within the recurrent CRC 11p15.5 amplicon 12,35 is supported by multiple criteria, including histologic transformation, proliferation and invasion. At the same time, the notion of Igf2 transforming activity is supported by blockade of Igf2-mediated tumorigenesis by a soluble Igfr2 receptor ectodomain 36 , and we observed modest npg t e c h n i c a l r e p o r t s miR-483 and IGF2 cooperativity, which could be more substantial with higher levels of overexpression.
Prior imprinting and Igf2 and Apc cooperation studies have attributed IGF2 locus oncogenicity in CRC to IGF2 itself 37, 38 , although these studies may have been confounded by the location of miR-483 within IGF2 intron 2 ( Supplementary Fig. 11 and Supplementary Discussion). miR-483 and IGF2 are tightly linked through co-overexpression in human CRC 12, 35 and in 92% of nonhypermutated IGF2-overexpressing TCGA CRC cases (22.4% overall frequency) 12 , likely reflecting their common transcript of origin. miR-483 knockdown modestly increases the spontaneous apoptosis rate of cultured HCT116 cells and the tumorigenicity of HepG2 cells more effectively than Igf2 knockdown in a liver cancer metastasis model 35 . However, neither the de novo transforming potential of miR-483 gain of function or overexpression nor the comparative oncogenicity of Igf2 compared to miR-483 in CRC has been previously demonstrated before now. Notably, miR-483 induced potent transformation and in vivo tumorigenicity compared with Kras G12D or knockdown of p53 or Smad4 in Apc-null organoids, suggesting particularly strong transforming activity perhaps originating in the ability of miRNAs to modulate diverse targets. The increased proliferation and invasion of primary colon organoids after Pdlim2 shRNA knockdown agrees with observations of decreased tumorigenicity as a result of PDLIM2 overexpression in CRC cell lines 39 and is consistent overall with PDLIM2 tumor suppressor function (Supplementary  Discussion) . Given the promiscuity of miRNA action, however, numerous other described and yet-undescribed targets probably contribute to miR-483 oncogenicity.
Overall these studies describe the successful in vitro oncogenic reprogramming of diverse gastrointestinal primary tissues in epithelial and mesenchymal organoids. This methodology should greatly facilitate cancer modeling and oncogene discovery and will complement existing in vitro cell line, iPS and in vivo screening methodologies 29, [31] [32] [33] [34] . The continued utilization of such models incorporating both tumor and stroma for in vitro 'cancer engineering' approaches 11 could be extended to embryonic stem cell-based epithelial and mesenchymal organoids 40 to investigate cancer biology and therapy. It will be interesting to further exploit the mesenchymal elements of organoids to model stromal regulation of cancer; we have previously documented endogenous paracrine Wnt and Notch signaling in intestinal organoids 9 . In addition, the general utility of primary organoid approaches to oncogene discovery, as demonstrated here, may be generalized to other tissues and screening approaches for therapeutic agents.
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